Skip to main content
Free trial

Ask AI to review this stock

Copy the prompt to get recent events, historical reactions, and a short research brief.

Tell your AI:

Help me set up FinLab and analyze 4131 浩泰. Please read: https://finlab.finance/en/setup?stock=4131

No install, open FinLab Studio

4131

浩泰 Biotech & Healthcare As of 2026-06-17 Updated daily after market close

quality needs a look, fair valuation.

1 active signal
Revenue ≥20%
This page refreshes daily after the close. Add 浩泰 to your watchlist to track signal changes on your next visit.
Valuation 13Quality 24Growth 94Momentum 49Chips 6

Is 浩泰 a buy? Fundamentals and valuation first

  • Weak profitability.Operating margin is in the 28th market percentile. Latest quarterly ROE ≈ -0.4%.

  • Foreign investors are net selling.Foreign 20-day net flow ≈ -7.0% of volume (net sell).

  • Strong revenue growth.Latest monthly revenue YoY ≈ 135.4%, above the 20% growth threshold.

  • Signals are active now.On the latest data, signals such as Revenue YoY ≥ 20% are active — see the historical forward returns after each occurrence below.

Chip flow

Bullish +0.33
BearishNeutralBullish

Institutional rotation, concentration steady — bullish

  • Institutional rotation, concentration steady — bullish
  • 兆豐-台南 holds 503 lots
  • sellers have 17 lots left, ~30 sessions to clear

Window from 2026-01-17 · Price -5% · branches to 2026-06-17· TDCC to 2026-06-12

  • Largest holder 兆豐-台南 has accumulated 503 lots since the start (sold 0%), holding.
  • Main distributor 群益金鼎 peaked at 268 lots, has sold 29%, 189 left, paused recently.
  • TDCC big holders (absolute) >1000-lot holders -0.57pp, mid holders +3, retail -3.33pp — little change.
  • Foreign hedge-desk net short Net short -6 lots (inferred from branch profile, mostly hedging — not necessarily bearish, not case-confirmed).
Branch inventory reconstruction
Accumulating holders Branches that accumulated shares during the window and still hold positive inventory; they are the absorbing side.
Distributing sellers Branches that built inventory earlier and have been selling it down; the remaining number estimates what has not cleared.
Net-short desks Trading-desk branches with negative inventory or net selling, often hedge, offsetting, or short-term flow. It is not automatically a bearish view.
Accumulating
兆豐-台南凱基-站前元富-西松臺銀國泰證券凱基
Distributing
群益金鼎凱基-台中富邦證券統一-台中凱基-台北富邦-新板
Desks
own scale
群益金鼎-潭子台新-西松永豐金-台中第一金-新興
Price Accumulating & Distributing share one scale (comparable); Desks is independent. Zero is the baseline
Branch details Unit: lots

Accumulating

  • 兆豐-台南 +503
    sold 0%
  • 凱基-站前 +267
    sold 0%
  • 元富-西松 +262
    sold 0%
  • 臺銀 +209
    sold 0%
  • 國泰證券 +130
    sold 9%
  • 凱基 +66
    sold 12%

Distributing

  • 群益金鼎 189 left
    sold 29%· paused recently
  • 凱基-台中 10 left
    sold 90%· ~4 sessions to clear
  • 富邦證券 20 left
    sold 71%· paused recently
  • 統一-台中 16 left
    sold 59%· paused recently
  • 凱基-台北 5 left
    sold 82%· paused recently
  • 富邦-新板 3 left
    sold 79%· ~30 sessions to clear

Desks

  • 群益金鼎-潭子 -323
    unclassified
  • 台新-西松 -252
    unclassified
  • 永豐金-台中 -229
    unclassified
  • 第一金-新興 -122
    unclassified
Still selling 17 lots ~30 sessions to bottom at most
Recent buy/sell force +51 absorbed / -31 sold buyers slightly ahead
Hedge-desk net short -1 lots potential cover-buying, not selling pressure
TDCC big holders · absolute-holding cross-check
>1000-lot holder share Retail (<400 lots) share Price (right axis)

Mixed direction: big-holder and retail changes are not aligned.

Describes chip flow, not investment advice. Branch data discloses only high-volume branches with ~1-day lag; TDCC is weekly. Inventory is a relative reconstruction from the window start, not absolute holdings.

Historical evidence

Signals active now

These signals are true on the latest data, with this stock's own historical forward-return stats after each occurrence.

Monthly revenue YoY ≥ 20% (from filing deadline)

Active · now 135.43%

Monthly revenue YoY ≥ 20%; event date is the first trading day after the filing deadline (no look-ahead).

100 historical occurrences (since 2007-04-23)
Average forward return after Monthly revenue YoY ≥ 20% (from filing deadline)。20-day: Win 41.6%, Sample 89, Median -0.85%, Excess +0.21%, Beat mkt rate 46.1%；60-day: Win 37.9%, Sample 87, Median -7.01%, Excess -4.67%, Beat mkt rate 35.6%；120-day: Win 33.7%, Sample 86, Median -11.04%, Excess -12.84%, Beat mkt rate 24.4%

120 days after: historical avg -9.26%

20-day +0.45%
60-day -3.62%
120-day -9.26%
20-day
60-day
120-day
Win
41.6%
37.9%
33.7%
Sample
89
87
86
Median
-0.85%
-7.01%
-11.04%
Excess
+0.21%
-4.67%
-12.84%
Beat mkt rate
46.1%
35.6%
24.4%

Over 86 occurrences, 120-day forward avg declined 9.26%, lagged the market by 12.84 pts; win rate 33.7%.

Does this signal hold up across the market

Over the past 242 months, on average ~404 stocks per month met “monthly revenue YoY ≥ 20%”; their adjusted-close return over the next 60 trading days averaged 6.94% (equal-weighted), beating the market by 2.37 points on average, and outperformed the TAIEX total-return index in 64.5% of months.

Each month, equal-weighted 60-day forward adjusted return of all signal-matching stocks, then averaged across months; excess vs the TAIEX total-return index.

Signals not active (historical stats for reference)

These are not occurring now; historical samples shown for comparison.

252-day price high (breakout)

Pending

Adjusted close makes a new 252-day high; repeats within 20 days counted once.

14 times historically; 60-day forward avg -5.42%, win rate 35.7%, beating the market by -8.51 pts on average.

Foreign net buying for 5 straight days

Pending

Foreign net flow (ex-dealer) positive for 5 straight days; event on day 5; repeats within 20 days counted once.

8 times historically; 60-day forward avg -10.73%, win rate 50%, beating the market by -18.55 pts on average.

Method and limitations

  • All returns use adjusted close (etl:adj_close), already adjusted for dividends and splits.
  • Excess return is measured against the TAIEX total-return index (dividends included).
  • Valuation regime and percentile stats use an expanding own-history window (no future data).
  • Revenue-signal event dates align to the first trading day after the filing deadline, avoiding look-ahead.
  • Event samples may overlap in time; stats describe historical distribution only and are less reliable when samples are few.

This page is historical statistics for educational purposes and is not investment advice. Investing involves risk; past performance does not indicate future results. Assess and bear the risk yourself before trading.